It could be a matter of pointing to the right research, and emphisising the need for patient-centred models of care. This is an excerpt from a report written by our firm, MAAP:

COMPLIMENTARY AND ALTERNATIVE MEDICINE: Children's Memorial Hospital in Chicago, Mayo Clinic, Duke University Medical Center, and the University of California, San Francisco and all the top 18 ‘honour roll’ hospitals in the US News Best American Hospitals list offer optional and additional complimentary and alternative medicine of some sort now including acupuncture, massage, reiki, yoga and other therapies (Moisse 2011). The driver for these services is primarily consumer demand, but as models of care progress toward better patient–centredness, consumer demands only get more salient. Therapists are most often nurses, but may also be specialist therapists or physicians (Cotton, Luberto et al. 2013).

Although many health professionals still think of such approaches as some kind of voodoo, an increasing number recognise their importance on the basis of real evidence. A recent study in US and Canadian paediatric hospitals showed that more than half the children (n=519, av age 10 yrs) who received alternative therapies reported very significant reductions in pain (average reductions of 34%), more than 75% showed very significant responses (-70%) in observed pain measurements (children are frequently too young to be able to express themselves fluently). Most of the children being treated were suffering from pain associated with cancer or cystic fibrosis (Cotton, Luberto et al. 2013).

Recommendations: • Provide specialisation and space (where required) for complimentary and alternative therapies. • Encourage a hospital culture that accepts the ethnic, personal and cultural needs and choices of patients.

reference: Smith, Mungo, Golembiewski, Jan, & Hyunh, Alison. (2013). Westmead Health Precinct: An International Review of Optimal Sizing of Children’s & Acute Hospitals. Report prepared for: NSW Health Infrastructure. Sydney. 

citations: 

Cotton, S., Luberto, C. M., Bogenschutz, L. H., Pelley, T. J., & Dusek, J. (2013). Integrative Care Therapies and Pain in Hospitalized Children and Adolescents: A Retrospective Database Review. J Altern Complement Med. doi: 10.1089/acm.2013.0306

Moisse, Katie. (2011). U.S. News and World Report Ranks Nation's Children's Hospitals. ABC News.

It must be registered to the Food and Drug Association of the New Country that traditional herbal medicine will integrate. Next, It should be done what the qualification of Herbs e.g. the efficacy and sfety with the certificate that  free from phatogenic microbiology.The next step must be tried to join with the Healthcare system by showing the  Evidence Based Herbal Medicine data after make attention of the profile of the diseases in the area observtions and  must be studied of the COMPLIMENTARY AND ALTERNATIVE MEDICINE in the area of New Country. If possible, try to join with the company that produce the herbal medicine by researching altogether. Example : Pasak Bumi from Indonesia (Eurycoma longiolia=Eurycoma sp)  is the one of the Magic Plant in the world that has many activity that has been used as an aphrodisiac. By  researching of preclinical experiment, It showed the increased of testosteron concentration after 2 weeks of oral administration and put in the copulaged offspring (1 male:5 female). The Result of the amount of child more decreased compare to the blank control group at the dosed administration and it was simillar to  follow the theory that the amount of sperm will increase but the amount of child will decrease with the vitality of spherm are stronger than the sperm of the blank control group ( no treatment by Eurycoma sp). I have ever present my material in 2008 (South Korea) and suggest to the world Lets to make a giant book in the world that content many million medicinal plant in the world to present this book for the next generation and the next generation will say thank you so much for our generation. Let's to do it altogether all over the world by supporting of United Nation.

One of the first rules for medicine should be "primum nil nocere" (first do no harm). So my question would be, why would you like to integrate herbal medicine into the existing healthcare system? Does integration absolutely have to happen or you can have two parallel systems (as in many other countries) and improve the safety of herbs delivered (as described by others above)? It seems you are aware there are very high risks at stake when it comes to ingesting/using substances. If you want integration of the systems, you would need to ensure nobody is harmed either by the dose they receive or potential pesticides or microbes. Can you build up a safe herb delivery system in Uganda? If not, you should not be advising your patients to consult a herbalist. There is of course a great potential placebo effect we are all aware. It would be pity to miss it, especially when resources are scarce and people cannot afford more advanced treatment. Jan has proposed many concepts that enabled acupuncture, massage, reiki, yoga and other similar therapies to be available to the patients. But in my opinion ensuring safety of herbal "medicines" is much more challenging than safety of these therapies. Also, environments are entirely different and people might have less official control and regulatory monitoring in Uganda than in western world. My advice is, if you want to integrate, make delivery of herbs safe first. That is a great focus to start with anyway. Basically, your second paragraph describes perfectly well where you could start - perhaps you should start with educating people delivering the herbs traditionally now, making sure that they know how to calculate doses and produce and deliver herbs in a safe way ("herb doctor workshops")? 

Automatically concluding that 'prepared at home' = unrefined is fraught. In many instances attempting to make herbal medicines 'safer' through the standardisation of pills etc may create its own problems, particularly with contamination and mislabelling of products (extraction methods can also create risks - see the example of the hepatotoxicity profile of solvent-based Kava extracts initially preferred by supplement manufacturers versus the traditional aqueous extracts)  

The World Health Organization also has document called Good Agricultural and Collection Practices in Herbal Medicines (http://apps.who.int/medicinedocs/en/d/Js4928e/), and ignoring these by a focus on GMP alone has been associated with poorer quality control. There are increasing studies of 'raw' e.g. infusion etc herbal interventions. The key is to educate those using and preparing the herbs how to do it safely.

However, some sort of regulation would be required to ensure the products are at least safe from contamination, and actually contain what they say they contain.

The initial steps to integration would be documenting use first to determine if and where any integration might be appropriate, and in what form this may be. You first need to find out what people are using, where they're getting this information, and develop infrastructure which trains conventional practitioners to ask and observe this use.

CAM practitioners can be utilised as reasonably powerful public health tools *if* they are appropriately accountable (usually through regulation), have a basic public health training and are willing to work with other providers. So this infrastructure would also need to be looked at if you wish to include the practitioner community.

The other obvious solution is to look at what other countries have done. South Africa and Zambia in the African setting have done some interesting work. Malaysia is integrating this though via MDs only meaning that it isn't always opted by the patients (who prefer to see a traditional herbalist).

I have some papers on regulation, integration and policy of CAM (and factors affecting these) on my profile which discuss this in a little more depth if you are interested. 

Perhaps this could be informative.

https://docs.google.com/viewer?url=http://worldteachertrust.org/_media/pdf/en/hospital.pdf&chrome=true

Regards

I am a master herbalist, but had to go to a "outside of the box" university to learn the information. We use herbs and whole food supplements from the best company in the U.S. that has research and manufacturing practices like any top notch pharmaceutical company. We are integrating courses in the medical and pharmacy school on this. Pharmacy schools used to teach pharmacognosy.

Any use of herbal medicine need to be based on some scientific evidence. People experience with traditional medicine can not be totally ignored., but it should not be the only  source of information.

Herbal medicine is becoming increasingly used to enhance general health and well-being, and it is also used alone for specific health problems or with modern medicine (Bruno and Ellis 2005; Kennedy 2005). A recent population study on 2526 adults from the Australian state of Victoria indicated that almost a quarter of the adult population used some form of herbal medicine in 2006–2007 (Zhang et al. 2008). Similarly, about one in five or an estimated 38.2 million adults in the United States used herbs and supplements in 2002, according to the National Health Interview Survey, which interviewed 31,044 representatives of the civilian noninstitutionalized population of the United States (Kennedy 2005). Established in 1999, the Consortium of Academic Health Centers for Integrative Medicine represents 44 academic health centers in the United States and Canada. The Consortium has been working on the inclusion of CAM knowledge, such as herbal therapies, into medical school curricula and the establishment of standards for research in integrative medicine and strategies in integrating alternative treatments into clinical care.

Currently, thousands of TM and other CAM herbal products are available as therapeutic agents worldwide. Yet few of these products have been subjected to randomized clinical trials (RCTs) under the International Conference on Harmonization (ICH) Good Clinical Practice Guidelines to determine their efficacy and/or safety (International Conference on Harmonization 2010.). Of the nearly 2000 herbal medicine clinical studies listed on the Cochrane Controlled Trials Register as of June 2009, most concern single-plant herbal or phytomedicine (www.thecochranelibrary.com). In recent years, in the case of multicomponent herbal medicines, an increased number of RCTs on traditional herbal medicine has been reported in the literature (World Health Organization 2004). For example, an Australian study on a Chinese herbal medicine prescription for the treatment of allergic rhinitis concluded that level II evidence is available that may substantiate the use of Chinese herbal medicine for both seasonal and perennial allergic rhinitis (Xue et al. 2003). Unfortunately, the quality of the majority of the clinical studies of herbal medicines reported to date is of great concern due to a number of factors that have rendered the data of dubious value. In a review of 206 RCTs on herbal medicine, which was published in Medline from 1966 to 2003, important methodological components of RCTs, particularly allocation concealment, generation of the allocation sequences, and intention-to-treat analyses, were incompletely reported. In these studies, only slightly over a quarter of the trials adequately reported blinding, and one-fifth reported generation of random allocation sequences (Gagnier et al. 2006). Furthermore, an earlier review of 2938 RCTs on TCM reported in 1980–1997 (Tang, Zhan, and Ernst 1999) concluded that the majority of these studies suffered from methodological defects. For example, only 15% of these studies used blinding, the sample size was mostly less than 300 patients, the controls were inadequate, few studies used quantitative outcome measures, and the studies were short term.

There have been many nonclinical in vitro and in vivo studies on herbal medicines that have commonly supported the traditional therapeutic claims. However, systematic reviews of the study protocols or the data interpretation and validation are lacking. Further, the translation of an in vitro and/or in vivo biological/pharmacological effect of a herbal medicine to human therapeutic use may not be successful due to species differences or other mitigating circumstances, including the simple attribute of a biological or clinical outcome by the name of the mother herb, while neglecting the type of plant extract, methods of processing, and pharmaceutical formulation, which invariably contain varying content and proportions of active chemical components (Brinker 2009).

In addition to the preclinical biological or pharmacological issues, the quality of the herbal products can affect the clinical outcomes and thus can impact their successful integration into EBM. Herbal medicine quality can be substantially different due to intrinsic and extrinsic factors. Species differences, organ specificity, and diurnal and seasonal variations are examples of intrinsic factors that can affect the qualitative and quantitative accumulation of the biologically or pharmacologically active chemical constituents produced and/or accumulated in the herb. Extrinsic factors affecting the quality of the herbal medicine include environmental conditions, cultivation and field collection practices, postharvest handling, storage, manufacturing, inadvertent contamination, substitution, and intentional adulteration (Awang 1997; Huang, Wen, and Hsiao 1997; Slifman et al. 1998; Mahady, Fong, and Farnsworth 2001; Cordell 2002; Fong 2002; Chadwick and Fong 2006).

I came across a really interesting model recently which is one where traditional medicine and modern medical approaches are offered - in the same clinic, side by side and without bias. Patients select what they need themselves, and with recommendations of other therapists in the clinic. It works really well - but possibly because it's a user pays system. (National health systems will always create a bias.) THe clinic is called Santé, in a town called Auroville, Tamil Nadu, India. Check it out if you're still interested. 

It must be scientifically validated that it is efficacious and is tolerable as per clinical trails. well packaged and formulated

It must first be accepted on the nations list of medicines.

If you use it among patients yet it does not meet the above criteria, then it remains a traditional medicine, not integrated into primary health care.